Selection of reperfusion therapy for individual patients with evolving myocardial infarction.
Publication
, Journal Article
Published in: Eur Heart J
September 1997
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Eur Heart J
DOI
ISSN
0195-668X
Publication Date
September 1997
Volume
18
Issue
9
Start / End Page
1371 / 1381
Location
England
Related Subject Headings
- Treatment Outcome
- Tissue Plasminogen Activator
- Time Factors
- Thrombolytic Therapy
- Risk Assessment
- Prognosis
- Plasminogen Activators
- Myocardial Reperfusion
- Myocardial Infarction
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Selection of reperfusion therapy for individual patients with evolving myocardial infarction. (1997). Eur Heart J, 18(9), 1371–1381. https://doi.org/10.1093/oxfordjournals.eurheartj.a015461
“Selection of reperfusion therapy for individual patients with evolving myocardial infarction.” Eur Heart J 18, no. 9 (September 1997): 1371–81. https://doi.org/10.1093/oxfordjournals.eurheartj.a015461.
Selection of reperfusion therapy for individual patients with evolving myocardial infarction. Eur Heart J. 1997 Sep;18(9):1371–81.
“Selection of reperfusion therapy for individual patients with evolving myocardial infarction.” Eur Heart J, vol. 18, no. 9, Sept. 1997, pp. 1371–81. Pubmed, doi:10.1093/oxfordjournals.eurheartj.a015461.
Selection of reperfusion therapy for individual patients with evolving myocardial infarction. Eur Heart J. 1997 Sep;18(9):1371–1381.
Published In
Eur Heart J
DOI
ISSN
0195-668X
Publication Date
September 1997
Volume
18
Issue
9
Start / End Page
1371 / 1381
Location
England
Related Subject Headings
- Treatment Outcome
- Tissue Plasminogen Activator
- Time Factors
- Thrombolytic Therapy
- Risk Assessment
- Prognosis
- Plasminogen Activators
- Myocardial Reperfusion
- Myocardial Infarction
- Humans